Interested in #OncoPharm, Data science, #Rstats, Visualisation. ⛵🍝🥌🏞️📷🖥️
Self declared geek.
Breast #bcsm, Prostate #pcsm, Lower GI #crcsm, Upper GI #esocsm & HPB #hpbcsm
chemo.org.uk
#PharmSky
Good luck. Hope this side of the fence is nicer. 🤞🏻
go.bsky.app/USU71ai
- Avoid large social gatherings
- Wash clothes w body fluids STAT
- Use a separate toilet
- Avoid all EtOH
- Avoid certain foods, coffee
--> lack evidence, cause harm academic.oup.com/jnci/article... great article from @csoncol.bsky.social #oncology
- Avoid large social gatherings
- Wash clothes w body fluids STAT
- Use a separate toilet
- Avoid all EtOH
- Avoid certain foods, coffee
--> lack evidence, cause harm academic.oup.com/jnci/article... great article from @csoncol.bsky.social #oncology
Wow. Rarely do I see a comments section so polarised.
"Charitable" sponsorship offering "access" to key people is dodgy in my eyes. It's interesting sitting on the sidelines watching this stuff. Having previously been among it. You don't see conflict you are among
Wow. Rarely do I see a comments section so polarised.
"Charitable" sponsorship offering "access" to key people is dodgy in my eyes. It's interesting sitting on the sidelines watching this stuff. Having previously been among it. You don't see conflict you are among
The saga of Cockcroft–Gault, FDA inertia, and the slow evolution of renal dosing equations.
🧮 pbfluids.com/2025/10/cock...
The saga of Cockcroft–Gault, FDA inertia, and the slow evolution of renal dosing equations.
🧮 pbfluids.com/2025/10/cock...
I think surely someone should have worked out the qwerty equivalent.
I think surely someone should have worked out the qwerty equivalent.
Adam Gripping of @mdanderson.bsky.social discusses association of improved OS in #NSCLC and #Melanoma with administration of a mRNA COVID vaccine
Translational work showing mechanism of increased INF-alpha leading to immune priming
Phase III in development… @oncoalert.bsky.social
Adam Gripping of @mdanderson.bsky.social discusses association of improved OS in #NSCLC and #Melanoma with administration of a mRNA COVID vaccine
Translational work showing mechanism of increased INF-alpha leading to immune priming
Phase III in development… @oncoalert.bsky.social
Impressive results. Let's hope it's affordable and deliverable.
🚨 BREAKING: DESTINY-Breast05 Phase III Results!
🎗️ Enhertu (trastuzumab deruxtecan) reduced the risk of recurrence or death by 53% vs. T-DM1 in high-risk HER2+ early breast cancer after neoadjuvant therapy.
🌟 Over 92% of patients on Enhertu remained free of invasive disease at 3 years.
Impressive results. Let's hope it's affordable and deliverable.
youtu.be/UAT-eOzeY4M?...
Fascinating.
I feel @paulb3964.bsky.social will either love this, or say surely we all already know it's not a phonetic alphabet and doesn't belong to NATO!
youtu.be/UAT-eOzeY4M?...
Fascinating.
I feel @paulb3964.bsky.social will either love this, or say surely we all already know it's not a phonetic alphabet and doesn't belong to NATO!
🚨BREAKING: Phase 3 Data!
📈 Osimertinib + chemotherapy significantly improved overall survival vs. Osimertinib alone in patients with EGFR-mutated advanced NSCLC.
✅ Reinforces its potential as a new first-line standard of care.
🔗 Read more: bit.ly/ONCOnews18O-1
🚨BREAKING: Phase 3 Data!
📈 Osimertinib + chemotherapy significantly improved overall survival vs. Osimertinib alone in patients with EGFR-mutated advanced NSCLC.
✅ Reinforces its potential as a new first-line standard of care.
🔗 Read more: bit.ly/ONCOnews18O-1
A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy - 2nd ed. (2025)
Head to https://ow.ly/rqaC50X9UPi under ‘Immune System and Malignant Disease’
#RPSLibrary
A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy - 2nd ed. (2025)
Head to https://ow.ly/rqaC50X9UPi under ‘Immune System and Malignant Disease’
#RPSLibrary
📅 Thu 26th & Fri 26th March
🗺️ Glasgow
💡 New refreshed agenda
💷 £50/day
❗️ Save the date #BOPAITC
bopa.org.uk/save-the-dat...
📅 Thu 26th & Fri 26th March
🗺️ Glasgow
💡 New refreshed agenda
💷 £50/day
❗️ Save the date #BOPAITC
bopa.org.uk/save-the-dat...
...I might never read them... But I don't think Google should delete them...
...I might never read them... But I don't think Google should delete them...
Which is interesting as you'd think big pharma will be knocking down their door to get them to use more expensive meds.. and clearly they are all in pharma's pocket
ja.ma/4pY0tTv
Which is interesting as you'd think big pharma will be knocking down their door to get them to use more expensive meds.. and clearly they are all in pharma's pocket
I'd never heard of Duffy null till the paper was added to the Journal Club potential discussion...
ja.ma/48mmCoo
I'd never heard of Duffy null till the paper was added to the Journal Club potential discussion...
I'm not sure " is the right symbology for transport signs and that upsets me more!
(4m boat width restriction could confuse if width is actually <4m. They probably checked)
www.bbc.co.uk/news/article...
I'm not sure " is the right symbology for transport signs and that upsets me more!
(4m boat width restriction could confuse if width is actually <4m. They probably checked)
www.bbc.co.uk/news/article...
1. Elaine Vickers despite being blown off, thinks our next big things will be RAS inhibitors, protein degraders and vaccines. Two of them at least might be useful in pancreatic cancer which could really do with a boost
1. Elaine Vickers despite being blown off, thinks our next big things will be RAS inhibitors, protein degraders and vaccines. Two of them at least might be useful in pancreatic cancer which could really do with a boost
Ever been to a Journal Club and not known what to do? Never been to a Journal Club at all...? Come for a chat through 4 papers with friends. Hopefully build confidence/ skills reading 🗞️
⏰10:30📍Meeting Room 1
#JournalClub
Ever been to a Journal Club and not known what to do? Never been to a Journal Club at all...? Come for a chat through 4 papers with friends. Hopefully build confidence/ skills reading 🗞️
⏰10:30📍Meeting Room 1
#JournalClub
If you are still in 🛏️... It's time to get up!
Elaine's going to tell us what's coming next
If you are still in 🛏️... It's time to get up!
Elaine's going to tell us what's coming next